Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges

Zsuzsanna Izsvák, Perry B. Hackett, Laurence J.N. Cooper, Zoltán Ivics

Research output: Contribution to journalReview article

77 Citations (Scopus)

Abstract

Recent results confirm that long-term expression of therapeutic transgenes can be achieved by using a transposon-based system in primary stem cells and in vivo. Transposable elements are natural DNA transfer vehicles that are capable of efficient genomic insertion. The latest generation, Sleeping Beauty transposon-based hyperactive vector (SB100X), is able to address the basic problem of non-viral approaches - that is, low efficiency of stable gene transfer. The combination of transposon-based non-viral gene transfer with the latest improvements of non-viral delivery techniques could provide a long-term therapeutic effect without compromising biosafety. The new challenges of pre-clinical research will focus on further refinement of the technology in large animal models and improving the safety profile of SB vectors by target-selected transgene integration into genomic "safe harbors." The first clinical application of the SB system will help to validate the safety of this approach.

Original languageEnglish (US)
Pages (from-to)756-767
Number of pages12
JournalBioEssays
Volume32
Issue number9
DOIs
StatePublished - Sep 1 2010

Fingerprint

Gene transfer
Beauty
Transgenes
Safety
DNA Transposable Elements
Therapeutic Uses
Ports and harbors
Stem cells
Genes
Animals
Stem Cells
Animal Models
Technology
DNA
Therapeutics
Research

Keywords

  • Integration
  • Non-viral
  • SB100x transposon
  • Therapy
  • Trial

Cite this

Translating Sleeping Beauty transposition into cellular therapies : Victories and challenges. / Izsvák, Zsuzsanna; Hackett, Perry B.; Cooper, Laurence J.N.; Ivics, Zoltán.

In: BioEssays, Vol. 32, No. 9, 01.09.2010, p. 756-767.

Research output: Contribution to journalReview article

Izsvák, Zsuzsanna ; Hackett, Perry B. ; Cooper, Laurence J.N. ; Ivics, Zoltán. / Translating Sleeping Beauty transposition into cellular therapies : Victories and challenges. In: BioEssays. 2010 ; Vol. 32, No. 9. pp. 756-767.
@article{ef21e4f1cf2f4403bb7f8ca426bf102c,
title = "Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges",
abstract = "Recent results confirm that long-term expression of therapeutic transgenes can be achieved by using a transposon-based system in primary stem cells and in vivo. Transposable elements are natural DNA transfer vehicles that are capable of efficient genomic insertion. The latest generation, Sleeping Beauty transposon-based hyperactive vector (SB100X), is able to address the basic problem of non-viral approaches - that is, low efficiency of stable gene transfer. The combination of transposon-based non-viral gene transfer with the latest improvements of non-viral delivery techniques could provide a long-term therapeutic effect without compromising biosafety. The new challenges of pre-clinical research will focus on further refinement of the technology in large animal models and improving the safety profile of SB vectors by target-selected transgene integration into genomic {"}safe harbors.{"} The first clinical application of the SB system will help to validate the safety of this approach.",
keywords = "Integration, Non-viral, SB100x transposon, Therapy, Trial",
author = "Zsuzsanna Izsv{\'a}k and Hackett, {Perry B.} and Cooper, {Laurence J.N.} and Zolt{\'a}n Ivics",
year = "2010",
month = "9",
day = "1",
doi = "10.1002/bies.201000027",
language = "English (US)",
volume = "32",
pages = "756--767",
journal = "BioEssays",
issn = "0265-9247",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Translating Sleeping Beauty transposition into cellular therapies

T2 - Victories and challenges

AU - Izsvák, Zsuzsanna

AU - Hackett, Perry B.

AU - Cooper, Laurence J.N.

AU - Ivics, Zoltán

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Recent results confirm that long-term expression of therapeutic transgenes can be achieved by using a transposon-based system in primary stem cells and in vivo. Transposable elements are natural DNA transfer vehicles that are capable of efficient genomic insertion. The latest generation, Sleeping Beauty transposon-based hyperactive vector (SB100X), is able to address the basic problem of non-viral approaches - that is, low efficiency of stable gene transfer. The combination of transposon-based non-viral gene transfer with the latest improvements of non-viral delivery techniques could provide a long-term therapeutic effect without compromising biosafety. The new challenges of pre-clinical research will focus on further refinement of the technology in large animal models and improving the safety profile of SB vectors by target-selected transgene integration into genomic "safe harbors." The first clinical application of the SB system will help to validate the safety of this approach.

AB - Recent results confirm that long-term expression of therapeutic transgenes can be achieved by using a transposon-based system in primary stem cells and in vivo. Transposable elements are natural DNA transfer vehicles that are capable of efficient genomic insertion. The latest generation, Sleeping Beauty transposon-based hyperactive vector (SB100X), is able to address the basic problem of non-viral approaches - that is, low efficiency of stable gene transfer. The combination of transposon-based non-viral gene transfer with the latest improvements of non-viral delivery techniques could provide a long-term therapeutic effect without compromising biosafety. The new challenges of pre-clinical research will focus on further refinement of the technology in large animal models and improving the safety profile of SB vectors by target-selected transgene integration into genomic "safe harbors." The first clinical application of the SB system will help to validate the safety of this approach.

KW - Integration

KW - Non-viral

KW - SB100x transposon

KW - Therapy

KW - Trial

UR - http://www.scopus.com/inward/record.url?scp=77956668327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956668327&partnerID=8YFLogxK

U2 - 10.1002/bies.201000027

DO - 10.1002/bies.201000027

M3 - Review article

C2 - 20652893

AN - SCOPUS:77956668327

VL - 32

SP - 756

EP - 767

JO - BioEssays

JF - BioEssays

SN - 0265-9247

IS - 9

ER -